Imperial College London
Alternate

DrRobertPerneczky

Faculty of Medicine, School of Public Health

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 0611r.perneczky

 
 
//

Location

 

10L05Lab BlockCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@inbook{Perneczky:2018:10.1007/978-1-4939-7704-8_2,
author = {Perneczky, R},
booktitle = {Biomarkers for Alzheimer’s Disease Drug Development},
doi = {10.1007/978-1-4939-7704-8_2},
editor = {Perneczky},
pages = {15--29},
publisher = {Springer},
title = {Population-based approaches to Alzheimer's disease prevention.},
url = {http://dx.doi.org/10.1007/978-1-4939-7704-8_2},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CHAP
AB  - Progress in prevention and treatment of Alzheimer's disease (AD) and dementia is hampered by the restricted understanding of the biological and environmental causes underlying pathophysiology. It is widely accepted that certain genetic factors are associated with AD and a number of lifestyle and other environmental characteristics have also been linked to dementia risk. However, interactions between genes and the environment are not yet well understood, and coordinated global action is required to utilize existing cohorts and other resources effectively and efficiently to identify new avenues for dementia prevention. This chapter provides a brief summary of current research on risk and protective factors and opportunities and challenges in relation to population-based approaches are discussed.
AU  - Perneczky,R
DO  - 10.1007/978-1-4939-7704-8_2
EP  - 29
PB  - Springer
PY  - 2018///
SP  - 15
TI  - Population-based approaches to Alzheimer's disease prevention.
T1  - Biomarkers for Alzheimer’s Disease Drug Development
UR  - http://dx.doi.org/10.1007/978-1-4939-7704-8_2
UR  - https://www.ncbi.nlm.nih.gov/pubmed/29512063
UR  - https://link.springer.com/protocol/10.1007%2F978-1-4939-7704-8_2
UR  - http://hdl.handle.net/10044/1/72644
ER  -
Download